![]() |
市场调查报告书
商品编码
1891547
角鲨烯市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2024-2032 年)Squalene Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast, 2024-2032 |
||||||
全球角鲨烯市场正经历强劲成长,这主要得益于化妆品、製药和个人护理行业需求的成长,以及对永续植物性成分的转向。 2024 年,全球角鲨烯市场价值为 1.696 亿美元。预计到 2025 年,市场规模将成长至 1.8503 亿美元,到 2032 年将达到 3.595 亿美元,在整个预测期内保持强劲成长。 2024 年,欧洲在全球角鲨烯市场占主导地位,市占率高达 47.88%。这得归功于先进的化妆品製造流程和以永续发展为导向的法规。
角鲨烯是一种天然存在的三萜烃 (C30H50)。角鲨烯传统上提取自鲨鱼肝油,但现在越来越多地从植物来源提取,例如橄榄油、小麦胚芽、甘蔗和苋菜籽。由于其优异的润肤性能、轻盈的质地以及与人体皮肤的高亲和力,角鲨烯被广泛应用于护肤品、化妆品、药品和功能性食品领域。
新冠疫情对市场的影响
新冠疫情对角鲨烯市场产生了复杂的影响。初期,经济的不确定性和可支配支出的减少导致对高端保养品的需求下降。然而,随着消费者居家时间增多,更加重视自我照护和健康,保养品的需求强劲反弹。
此外,製药业在疫情期间成为主要的成长动力。角鲨烯被广泛用作疫苗製剂中的佐剂,以增强免疫反应和疫苗效力。新冠疫苗的大规模生产显着增加了製药厂商对角鲨烯的需求,进一步巩固了角鲨烯在全球医疗保健供应链中的战略重要性。
市场趋势
影响角鲨烯市场的关键趋势包括对永续采购和植物基角鲨烯日益增长的需求。消费者和品牌对环境永续性、海洋保护和动物福利的日益关注,正促使他们逐步淘汰鲨鱼来源的成分。
源自橄榄、甘蔗和苋菜籽的植物基角鲨烯,提供了不经动物实验且环保的替代方案。化妆品和个人护理品牌越来越致力于符合道德规范的采购和永续发展目标,这使得植物基角鲨烯成为更受欢迎的成分。监管审查的加强和消费者对成分来源透明度的需求,进一步推动了这一转变。
市场成长驱动因素
化妆品和护肤品产业仍然是角鲨烯市场成长的关键推动力。角鲨烯因其深层保湿、提升肌肤弹性和修復肌肤屏障且不留黏腻残留的特性而备受推崇。随着消费者越来越注重护肤,对高效天然成分的需求也正在加速成长。
该产品符合清洁美容和天然配方趋势,进一步促进了其市场普及。此外,其抗衰老特性使其成为高端护肤品、精华液、保湿霜和抗皱配方中备受青睐的成分。
另一个关键驱动因素是角鲨烯作为疫苗佐剂在医药领域的应用日益广泛。角鲨烯佐剂能够增强免疫反应,进而提高疫苗的有效性。其在新冠疫苗配方中的应用显着提升了市场需求。对其免疫调节特性和先进药物递送系统的持续研究预计将在整个预测期内维持医药领域的需求。
市场限制因子
儘管成长前景强劲,但由于与鲨鱼来源角鲨烯相关的环境和伦理问题,市场面临诸多限制因素。过度捕捞鲨鱼以提取肝油引发了人们对生物多样性和海洋生态系统的严重担忧。这些问题导致监管审查加大,消费者抵制情绪高涨,限制了动物来源角鲨烯在多个地区的接受度。
依原料划分,截至2024年,动物来源细分市场占主导地位。这主要是由于鲨鱼来源角鲨烯在化妆品和医药领域长期使用。然而,由于永续发展倡议和符合伦理的采购要求,植物来源细分市场预计将呈现最高的成长率。
依终端用户产业划分,化妆品产业在2024年占最大的市场占有率,这主要得益于其在护肤品中的广泛应用。製药业也占了相当大的占有率,这主要归功于疫苗的研发和免疫计画的扩展。
2024年,欧洲在全球角鲨烯市场中占领先地位,市场规模达8,120万美元。该地区受益于强大的化妆品製造能力、消费者对清洁标籤产品的高需求以及对永续采购实践的早期采用。
北美地区保养品市场需求强劲。同时,由于製药业的扩张和疫苗产量的增加,亚太地区预计将快速成长。拉丁美洲拥有丰富的植物原料,因此在采购方面具有优势,而中东和非洲地区对永续化妆品原料的需求也不断增长。
The global squalene market is witnessing strong expansion, driven by increasing demand from the cosmetics, pharmaceutical, and personal care industries, alongside a growing shift toward sustainable and plant-based ingredients. In 2024, the global squalene market size was valued at USD 169.6 million. The market is projected to grow to USD 185.03 million in 2025 and further reach USD 359.5 million by 2032, reflecting robust growth over the forecast period. Europe dominated the global squalene market in 2024, accounting for a 47.88% market share, supported by advanced cosmetic manufacturing and sustainability-focused regulations.
Squalene is a naturally occurring triterpene hydrocarbon (C30H50), traditionally sourced from shark liver oil and increasingly derived from plant-based alternatives such as olive oil, wheat germ, sugarcane, and amaranth seed. Due to its excellent emollient properties, lightweight texture, and high compatibility with human skin, squalene is widely used in skincare, cosmetics, pharmaceuticals, and functional food applications.
Impact of COVID-19 on the Market
The COVID-19 pandemic had a mixed impact on the squalene market. During the initial phase, demand for luxury skincare products declined due to economic uncertainty and reduced discretionary spending. However, as consumers spent more time at home and prioritized self-care and wellness, demand for skincare products rebounded strongly.
Additionally, the pharmaceutical industry emerged as a key growth contributor during the pandemic. Squalene is widely used as an adjuvant in vaccine formulations, enhancing immune response and vaccine effectiveness. The mass production of COVID-19 vaccines led to a notable surge in demand from pharmaceutical manufacturers, reinforcing the strategic importance of squalene in global healthcare supply chains.
Market Trends
A key trend shaping the squalene market is the rising demand for sustainably sourced and plant-based squalene. Growing awareness around environmental sustainability, marine conservation, and animal welfare has led consumers and brands to move away from shark-derived sources.
Plant-based squalene sourced from olives, sugarcane, and amaranth seed offers a cruelty-free and environmentally responsible alternative. Cosmetic and personal care brands are increasingly committing to ethical sourcing and sustainability goals, making plant-derived squalene a preferred ingredient. This shift is further supported by regulatory scrutiny and consumer demand for transparency in ingredient sourcing.
Market Growth Drivers
The cosmetics and skincare industry remains the primary growth driver for the squalene market. Squalene is valued for its ability to deeply moisturize, improve skin elasticity, and restore the skin barrier without leaving a greasy residue. As consumer focus on skincare routines continues to grow, demand for high-performance, naturally derived ingredients is accelerating.
The product's alignment with clean beauty and natural formulation trends further strengthens its adoption. In addition, its anti-aging properties make it a highly desirable ingredient in premium skincare products, serums, moisturizers, and anti-wrinkle formulations.
Another major driver is the growing pharmaceutical application of squalene as a vaccine adjuvant. Squalene-based adjuvants enhance immune response, enabling improved vaccine efficacy. Their use in COVID-19 vaccine formulations significantly boosted market demand. Ongoing research into immunomodulatory properties and advanced drug delivery systems is expected to sustain pharmaceutical sector demand over the forecast period.
Market Restraints
Despite strong growth prospects, the market faces restraints related to environmental and ethical concerns associated with shark-derived squalene. Overexploitation of sharks for liver oil extraction has raised serious biodiversity and marine ecosystem concerns. These issues have led to increased regulatory scrutiny and consumer backlash, limiting acceptance of animal-derived squalene in several regions.
By source, the animal segment dominated the market in 2024, owing to the long-standing use of shark-derived squalene in cosmetics and pharmaceuticals. However, the plant segment is expected to grow at the fastest rate, driven by sustainability initiatives and ethical sourcing requirements.
By end-use industry, the cosmetics segment held the largest market share in 2024, supported by widespread adoption in skincare formulations. The pharmaceutical segment also accounted for a significant share due to vaccine development and expanding immunization programs.
Europe led the global squalene market in 2024, with a market size of USD 81.2 million. The region benefits from strong cosmetic manufacturing capabilities, high consumer demand for clean-label products, and early adoption of sustainable sourcing practices.
North America shows strong demand from the skincare sector, while Asia Pacific is expected to witness rapid growth due to pharmaceutical expansion and increasing vaccine production. Latin America offers sourcing advantages due to abundant plant-based raw materials, while the Middle East & Africa is experiencing growing demand for sustainable cosmetic ingredients.
Competitive Landscape
Key players in the squalene market are focusing on product development, sustainable sourcing, and capacity expansion to strengthen their market presence. Companies are increasingly investing in plant-based and biosynthetic alternatives to address ethical concerns and meet evolving consumer expectations.
With rising demand from skincare, pharmaceuticals, and sustainability-driven industries, the global squalene market is positioned for strong growth through 2032.
Segmentation By Source
By End-Use Industry
By Region